Emerald Clinics Ltd (ASX:EMD) shareholder Craig Darby has increased his stake in the company to 11.87% from 10.66%.
The increase came after Darby purchased a total of 2.225 million shares in the company on March 10 and 23 worth $19,912 and $80,000 respectively.
He now holds a total of 21.82 million shares in the company.
Shares today have been up almost 16% to 8 cents.
Plans to extend real-world evidence platform
The company has confirmed that business is stable despite the restrictions being enforced across Australia due to COVID-19, with the patient count continuing to grow, referrals remaining steady and around 80% of recent appointments completed via telehealth.
Emerald plans to extend its real-world evidence (RWE) platform, which it believes could support the growing need to monitor COVID-19 patients and those self-isolating.
Managing director and chief executive officer Dr Michael Winlo said: “Our team has been working quickly to extend our RWE platform so we can help address the COVID-19 pandemic for Australian patients and citizens.
“Emerald has unique resources such as a team of research-focused clinicians, a RWE platform and a Telehealth service that can respond to the circumstances.
“We look forward to exploring this further with several interested parties.”